{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:41:39Z","timestamp":1791848499508,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.cell.2024.08.043","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T10:35:55Z","timestamp":1725446155000},"page":"5540-5553.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates"],"prefix":"10.1016","volume":"187","author":[{"given":"Eric M.","family":"Mucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec W.","family":"Freyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Bixler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Cizmeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Atyeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Earl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genesis","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany R.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael H.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Meni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guha A.","family":"Arunkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Stadlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Jorquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamilton","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kath","family":"Hardcastle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Americo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff W.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher I.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Shamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Lynne","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keersten M.","family":"Ricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Carfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2024.08.043_bib1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/infdis\/140.3.440","article-title":"Smallpox: clinical types, causes of death, and treatment","volume":"140","author":"Koplan","year":"1979","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2024.08.043_bib2","first-page":"165","article-title":"Human monkeypox, 1970\u201379","volume":"58","author":"Breman","year":"1980","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.cell.2024.08.043_bib4","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2024.08.043_bib6","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2024.08.043_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.15585\/mmwr.mm7220a4","article-title":"Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022","volume":"72","author":"Rosenberg","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.cell.2024.08.043_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States","volume":"72","author":"Dalton","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.cell.2024.08.043_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102407","article-title":"Impact of vaccination and high-risk group awareness on the mpox epidemic in the United States, 2022\u20132023: a modelling study","volume":"68","author":"Lin","year":"2024","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.cell.2024.08.043_bib11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41591-023-02229-3","article-title":"Real-world effectiveness of a single dose of mpox vaccine in males","volume":"29","author":"Wolff Sagy","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2024.08.043_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA Vaccines in the COVID-19 Pandemic and Beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cell.2024.08.043_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2024.08.043_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.cell.2024.08.043_bib15","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2024.08.043_bib16","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2024.08.043_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1743-422X-8-441","article-title":"Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease","volume":"8","author":"Golden","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.cell.2024.08.043_bib18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine\u2013induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2024.08.043_bib19","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.cell.2024.08.043_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3540","article-title":"An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge","volume":"15","author":"Freyn","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2024.08.043_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","article-title":"Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus","volume":"8","author":"Sang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2024.08.043_bib22","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.15585\/mmwr.mm7149a5","article-title":"Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43\u00a0U.S. Jurisdictions, July 31\u2013October 1, 2022","volume":"71","author":"Payne","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.cell.2024.08.043_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.cell.2024.08.043_bib24","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1016\/j.vaccine.2020.07.018","article-title":"Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus","volume":"38","author":"Xiao","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.cell.2024.08.043_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcpa.2012.06.007","article-title":"Comparative Pathology of Smallpox and Monkeypox in Man and Macaques","volume":"148","author":"Cann","year":"2013","journal-title":"J.\u00a0Comp. Pathol."},{"key":"10.1016\/j.cell.2024.08.043_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2217\/fvl.12.130","article-title":"A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012","volume":"8","author":"Parker","year":"2013","journal-title":"Future Virol."},{"key":"10.1016\/j.cell.2024.08.043_bib27","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in\u00a0vitro and protection in\u00a0vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2024.08.043_bib28","series-title":"Weekly Event Based Surveillance Report","year":"2024"},{"key":"10.1016\/j.cell.2024.08.043_bib29","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","article-title":"A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease","volume":"187","author":"Zuiani","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cell.2024.08.043_bib30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.chom.2023.05.001","article-title":"Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals","volume":"31","author":"Hubert","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2024.08.043_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008505","article-title":"Natural killer cells expanded in\u00a0vivo or ex\u00a0vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses","volume":"16","author":"Earl","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2024.08.043_bib32","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1186\/s12879-022-07900-7","article-title":"Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease","volume":"22","author":"Sukhdeo","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cell.2024.08.043_bib33","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.vaccine.2006.10.047","article-title":"Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naive and vaccinia-immune individuals","volume":"25","author":"Parrino","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.cell.2024.08.043_bib34","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2024.08.043_bib35","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.48.2200894","article-title":"Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022","volume":"27","author":"Berens-Riha","year":"2022","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.cell.2024.08.043_bib36","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S1473-3099(23)00546-7","article-title":"Mpox breakthrough infections: concerns and actions","volume":"23","author":"Taha","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cell.2024.08.043_bib37","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2024.08.043_bib38","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 - Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2024.08.043_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1255935","article-title":"Functional epitopes and neutralizing antibodies of vaccinia virus","volume":"14","author":"Peng","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cell.2024.08.043_bib40","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(22)01436-2","article-title":"Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study","volume":"400","author":"Tar\u00edn-Vicente","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2024.08.043_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004904","article-title":"Extracellular Virions: The Advance Guard of Poxvirus Infections","volume":"11","author":"Pickup","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2024.08.043_bib42","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2024.08.043_bib43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3201\/eid3001.231164","article-title":"Clade I\u2013Associated Mpox Cases Associated with Sexual Contact, the Democratic Republic of the Congo","volume":"30","author":"Kibungu","year":"2024","journal-title":"Emerging Infect.Dis."},{"key":"10.1016\/j.cell.2024.08.043_bib44","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.11.2400106","article-title":"Ongoing mpox outbreak in Kamituga, South Kivu province, associated with monkeypox virus of a novel Clade I sub-lineage, Democratic Republic of the Congo, 2024","volume":"29","author":"Masirika","year":"2024","journal-title":"Euro Surveill."},{"key":"10.1016\/j.cell.2024.08.043_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cell.2024.08.043_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01504-21","article-title":"A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge","volume":"96","author":"Mucker","year":"2022","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2024.08.043_bib47","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1056\/NEJMe2028079","article-title":"The Power of Antibody-Based Surveillance","volume":"383","author":"Alter","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2024.08.043_bib48","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of Humoral Immunity to Common Viral and Vaccine Antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2024.08.043_bib49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(22)00764-2","article-title":"The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials","volume":"23","author":"Essink","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cell.2024.08.043_bib50","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.immuni.2024.01.017","article-title":"SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase","volume":"57","author":"Srivastava","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2024.08.043_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cell.2021.12.002","article-title":"Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung","volume":"185","author":"Gagne","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cell.2024.08.043_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.virol.2020.02.004","article-title":"Particle-specific neutralizing activity of a monoclonal antibody targeting the poxvirus A33 protein reveals differences between cell associated and extracellular enveloped virions","volume":"544","author":"Mucker","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.cell.2024.08.043_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/v14081741","article-title":"Effect of Monkeypox Virus Preparation on the Lethality of the Intravenous Cynomolgus Macaque Model","volume":"14","author":"Mucker","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2024.08.043_bib54","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","article-title":"A tale of two clades: monkeypox viruses","volume":"86","author":"Likos","year":"2005","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.cell.2024.08.043_bib55","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1128\/JVI.77.19.10684-10688.2003","article-title":"Development and Use of a Vaccinia Virus Neutralization Assay Based on Flow Cytometric Detection of Green Fluorescent Protein","volume":"77","author":"Earl","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2024.08.043_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03586-23","article-title":"Orally available nucleoside analog UMM-766 provides protection in a murine model of orthopox disease","volume":"12","author":"Mudhasani","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.cell.2024.08.043_bib57","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/AAC.46.5.1329-1335.2002","article-title":"Characterization of Wild-Type and Cidofovir-Resistant Strains of Camelpox, Cowpox, Monkeypox, and Vaccinia Viruses","volume":"46","author":"Smee","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cell.2024.08.043_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0166-3542(01)00217-0","article-title":"Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug","volume":"54","author":"Smee","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cell.2024.08.043_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/v14091993","article-title":"Evaluation of Virulence in Cynomolgus Macaques Using a Virus Preparation Enriched for the Extracellular Form of Monkeypox Virus","volume":"14","author":"Mucker","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2024.08.043_bib59","series-title":"DNA Viruses","author":"Moss","year":"2021"},{"key":"10.1016\/j.cell.2024.08.043_bib61","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA Vaccination with Vaccinia Virus L1R and A33R Genes Protects Mice against a Lethal Poxvirus Challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.cell.2024.08.043_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.07.002","article-title":"A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation","volume":"473","author":"Fischinger","year":"2019","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.cell.2024.08.043_bib63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jim.2019.05.006","article-title":"A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis","volume":"471","author":"Karsten","year":"2019","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.cell.2024.08.043_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31169-8","article-title":"Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms","volume":"13","author":"Atyeo","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867424009723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867424009723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:51:53Z","timestamp":1762231913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867424009723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":61,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0092867424009723"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2024.08.043","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2024.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}